Lecturers Shigeki Tatsuno, Partner, Anderson Mori & Tomotsune |
With the Amended Whistleblower Protection Act coming into effect in June 2022, an official manual has been published in October 2021 for the Guidelines. Corporations are required to accurately understand the amendments, the Guidelines, and the manual, and to immediately organize their systems.
Internal reporting systems ensure corporate compliance and play an important role in enhancing corporate value. Therefore, it is necessary to consider how internal reporting systems should be positioned within a company’s compliance system and its overall framework as a function to prevent misconduct.
This seminar will guide you through the Amended Whistleblower Protection Act based on practical examples of how internal reporting systems should be utilized to prevent misconduct and what points to keep in mind.
Overview | |
Date and Time | Wednesday, March 16, 2022 2 pm – 5 pm |
---|---|
How to Apply | The seminar will be a LiVECAST webinar. You will be able to join from anywhere as long as you have internet access. After you sign up, we will send you the link together with details on how to join the seminar. |
Entry fee | 20,000 JPY (incl. tax) Note: 10,000 JPY (incl. tax) if you sign up before Monday, March 7, 2022 |
Registration | Reception has been closed. Thank you for your entry. |
Program | |
2 pm – 3:25 pm | Part 1 – The Amended Whistleblower Protection Act and Practical Use to Prevent Corporate Misconduct (1) (Key points of the Amended Whistleblower Protection Act and Guidelines) |
---|---|
3:25 pm -3:35 pm | Break |
3:35 pm – 5:00 pm | Part 2 The Amended Whistleblower Protection Act and Practical Use to Prevent Corporate Misconduct (2) (Utilizing internal reporting systems to prevent misconduct) |
Lecturers
Anderson Mori & Tomotsune
Shigeki Tatsuno, Partner
Graduated from The University of Tokyo (LL.B.) in 2000. Registered as a lawyer and joined Anderson Mori & Tomotsune in 2002. Graduated from the New York University School of Law (LL.M.) in the United States in 2007. Registered in New York State in 2008. Worked for Herbert Smith in Paris, France from 2007 to 2008. Member of the Human Research Ethics Review Committee of Graduate School of Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, The University of Tokyo since November 2014. Involved in numerous M&As and startup investments in and out of Japan. Has a thorough knowledge of corporate governance and compliance issues and advises clients not only from legal perspectives but also taking corporate strategies into account. Handles matters related to healthcare, transactions and regulations for fields including AI and data, and other corporate legal affairs. Selected as one of the two most prominent lawyers in the fields of M&A and the Companies Act in the November 7, 2020 issue of Weekly Toyo Keizai,.